Search

Displaying results 5791 - 5800 of 6076 in total
  1. Drug

    LY-517717

    go.drugbank.com/drugs/DB05713
    Investigational

    LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen).

  2. Drug

    CRx-401

    go.drugbank.com/drugs/DB05775
    Experimental

    CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate,...

  3. Drug

    AL-02

    go.drugbank.com/drugs/DB06065
    Experimental

  4. Drug

    TG1024

    go.drugbank.com/drugs/DB06180
    Experimental

  5. Drug

    Ocaperidone

    go.drugbank.com/drugs/DB06229
    Experimental

  6. Drug

    Relacatib

    go.drugbank.com/drugs/DB06367
    Investigational

  7. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

  8. Drug

    Mitumomab

    go.drugbank.com/drugs/DB06462
    Experimental

    Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.

  9. Drug

    Sufugolix

    go.drugbank.com/drugs/DB06494
    Experimental

  10. Drug

    AMGN-0007

    go.drugbank.com/drugs/DB06511
    Experimental

    Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.